Pathogen: SARS-CoV-2

MULTI-COVID

Italy
|
2023-2023
  • Adults
  • Elderly
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

NOVELLA

Russian Federation
|
2023-2024
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • AZD3152

Oliván-Blázquez

Spain
|
2022
  • Adults
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

PanoramicNOR

Norway
|
2023-2026
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir

Peghetti

Italy
|
2021-2023
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

PHOSP-COVID

United Kingdom
|
2020
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

Plaza

Spain
|
2023-2025
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

LongCoCid

Germany
|
2022
  • General population
  • Paediatric
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Long-Neuro-COVID-19

Germany
|
2020-2024
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

López-González

Spain
|
2021
  • Adults
  • General population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

LoTECA

Norway
|
2021-2022
  • Adults
  • General population
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

LUNGTERMcov

Switzerland
|
2021-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19